Publication:
Recommendations for hepatitis B immunoglobulin and antiviral prophylaxis against hepatitis B recurrence after liver transplantation

Simple item page
dc.contributor.coauthorAkarsu, Mesut
dc.contributor.coauthorÖnem, Soner
dc.contributor.coauthorTuran, İlker
dc.contributor.coauthorAdalı, Gupse
dc.contributor.coauthorAkdoğan, Meral
dc.contributor.coauthorAladağ, Murat
dc.contributor.coauthorBalaban, Yasemin
dc.contributor.coauthorDanış, Nilay
dc.contributor.coauthorDayangaç, Murat
dc.contributor.coauthorGökcan, Hale
dc.contributor.coauthorSertesen, Elif
dc.contributor.coauthorGürakar, Merve
dc.contributor.coauthorHarputluoğlu, Murat
dc.contributor.coauthorKabacam, Gökhan
dc.contributor.coauthorKarademir, Sedat
dc.contributor.coauthorKıyıcı, Murat
dc.contributor.coauthorİdilman, Ramazan
dc.contributor.coauthorKarasu, Zeki
dc.contributor.kuauthorAkyıldız, Murat
dc.contributor.kuauthorGençdal, Genco
dc.contributor.kuprofileFaculty Member
dc.contributor.kuprofileDoctor
dc.contributor.schoolcollegeinstituteSchool of Medicine
dc.contributor.unitKoç University Hospital
dc.contributor.yokid123080
dc.contributor.yokidN/A
dc.date.accessioned2024-11-09T13:47:48Z
dc.date.issued2021
dc.description.abstractThe combination of hepatitis B immunoglobulin and potent nucleos(t)ide analogs after liver transplantation is considered as the standard of care for prophylaxis against hepatitis B virus recurrence. However, the recommended doses, route of administration, and duration of HBIG administration remain unclear. Moreover, hepatitis B immunoglobulin-free prophylaxis with potent nucleos(t)ide analogs has shown promising disease outcomes in preventing hepatitis B virus recurrence. The current recommendations, produced by the Turkish Association for the Study of the Liver, Acute Liver Failure and Liver Transplantation Special Interest Group, suggest a reduced need for hepatitis B immunoglobulin administration with effective long-term suppression of hepatitis B virus replication using potent nucleos(t)ide analogs after liver transplantation.
dc.description.fulltextYES
dc.description.indexedbyWoS
dc.description.indexedbyScopus
dc.description.indexedbyPubMed
dc.description.indexedbyTR Dizin
dc.description.issue9
dc.description.openaccessYES
dc.description.publisherscopeNational
dc.description.sponsoredbyTubitakEuN/A
dc.description.sponsorshipN/A
dc.description.versionPublisher version
dc.description.volume32
dc.formatpdf
dc.identifier.doi10.5152/tjg.2021.21608
dc.identifier.eissn2148-5607
dc.identifier.embargoNO
dc.identifier.filenameinventorynoIR03288
dc.identifier.linkhttps://doi.org/10.5152/tjg.2021.21608
dc.identifier.quartileQ4
dc.identifier.scopus2-s2.0-85117952374
dc.identifier.urihttps://hdl.handle.net/20.500.14288/3788
dc.identifier.wos703346600001
dc.keywordsHepatitis B
dc.keywordsLiver transplantation
dc.keywordsRecurrence
dc.languageEnglish
dc.publisherAves
dc.relation.grantnoNA
dc.relation.urihttp://cdm21054.contentdm.oclc.org/cdm/ref/collection/IR/id/10072
dc.sourceTurkish Journal of Gastroenterology
dc.subjectGastroenterology and hepatology
dc.titleRecommendations for hepatitis B immunoglobulin and antiviral prophylaxis against hepatitis B recurrence after liver transplantation
dc.typeReview
dspace.entity.typePublication
local.contributor.authorid0000-0002-2080-7528
local.contributor.authoridN/A
local.contributor.kuauthorAkyıldız, Murat
local.contributor.kuauthorGençdal, Genco

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
10072.pdf
Size:
1.07 MB
Format:
Adobe Portable Document Format
Download

Collections

Publications with Fulltext